Lipocine Inc. SEC filings LPCN
Lipocine Inc. has 823 filings in SEC EDGAR's recent list, going back to Nov 30, 2011. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 9, 2026 | — |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Apr 26, 2024 | — |
| S-3/A | Filing | Apr 23, 2024 | — |
| S-3 | Shelf registration | Nov 22, 2023 | — |
| 424B5 | Prospectus supplement | Apr 3, 2023 | — |
| 424B5 | Prospectus supplement | Jan 27, 2021 | — |
| 424B5 | Prospectus supplement | Jan 25, 2021 | — |
| S-3 | Shelf registration | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Aug 21, 2020 | — |
| 424B5 | Prospectus supplement | Aug 6, 2020 | — |
| S-8 | Employee stock plan registration | Jul 30, 2020 | — |
| 424B5 | Prospectus supplement | Apr 10, 2020 | — |
| 424B5 | Prospectus supplement | Feb 26, 2020 | — |
| 424B5 | Prospectus supplement | Nov 15, 2019 | — |
| 424B5 | Prospectus supplement | Nov 14, 2019 | — |
| 424B5 | Prospectus supplement | Nov 13, 2019 | — |
| 424B5 | Prospectus supplement | Nov 7, 2019 | — |
| 424B5 | Prospectus supplement | Sep 20, 2018 | — |
| S-8 | Employee stock plan registration | Aug 8, 2018 | — |
| S-3/A | Filing | Nov 17, 2017 | — |
| S-3 | Shelf registration | Oct 13, 2017 | — |
| 424B5 | Prospectus supplement | Mar 6, 2017 | — |
| S-8 | Employee stock plan registration | Nov 8, 2016 | — |
| 424B5 | Prospectus supplement | Apr 24, 2015 | — |
| 424B5 | Prospectus supplement | Apr 23, 2015 | — |
| POS AM | Filing | Oct 22, 2014 | — |
| 424B3 | Prospectus | Oct 14, 2014 | — |
| S-3 | Shelf registration | Oct 1, 2014 | — |
| 424B3 | Prospectus | Sep 24, 2014 | — |
| 424B3 | Prospectus | Sep 8, 2014 | — |
| 424B3 | Prospectus | Aug 13, 2014 | — |
| 424B3 | Prospectus | Jul 15, 2014 | — |
| S-8 | Employee stock plan registration | Jul 15, 2014 | — |
| 424B3 | Prospectus | Jun 11, 2014 | — |
| 424B3 | Prospectus | May 27, 2014 | — |
| 424B3 | Prospectus | May 15, 2014 | — |
| 424B3 | Prospectus | May 13, 2014 | — |
| 424B3 | Prospectus | Apr 29, 2014 | — |
| 424B3 | Prospectus | Apr 10, 2014 | — |
| POS AM | Filing | Mar 31, 2014 | — |
| 424B3 | Prospectus | Mar 18, 2014 | — |
| 424B3 | Prospectus | Feb 10, 2014 | — |
| 424B3 | Prospectus | Jan 24, 2014 | — |
| 424B3 | Prospectus | Jan 8, 2014 | — |
| 424B4 | Prospectus | Nov 27, 2013 | — |
| S-1MEF | Filing | Nov 26, 2013 | — |
| S-1/A | Amended registration statement | Nov 21, 2013 | — |
| S-1/A | Amended registration statement | Nov 15, 2013 | — |
| 424B3 | Prospectus | Nov 13, 2013 | — |
| S-1 | Registration statement | Nov 4, 2013 | — |
| S-8 | Employee stock plan registration | Oct 11, 2013 | — |
| 424B3 | Prospectus | Sep 27, 2013 | — |
| S-1/A | Amended registration statement | Sep 25, 2013 | — |
| S-1 | Registration statement | Aug 29, 2013 | — |
| S-1/A | Amended registration statement | Feb 10, 2012 | — |
| S-1/A | Amended registration statement | Feb 1, 2012 | — |
| S-1/A | Amended registration statement | Jan 23, 2012 | — |
| S-1/A | Amended registration statement | Jan 13, 2012 | — |
| S-1/A | Amended registration statement | Dec 29, 2011 | — |
| S-1 | Registration statement | Nov 30, 2011 | — |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LPCN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, United States
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1535955
- Former names
- MARATHON BAR CORP (until Jul 9, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.